"We might raise little more private equity prior to IPO. This basically gives an idea of where we believe we can unlock the value in terms of Biocon Biologics in the next few years," she said.from Moneycontrol Business News https://ift.tt/35yQZ6F
Tuesday, January 7, 2020
Biocon Biologics can achieve $1 bn revenue by 2022: Kiran Mazumdar Shaw
"We might raise little more private equity prior to IPO. This basically gives an idea of where we believe we can unlock the value in terms of Biocon Biologics in the next few years," she said.from Moneycontrol Business News https://ift.tt/35yQZ6F
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment